The Risk of Multiple Sclerosis Relapse After Vaccination: Can a Population-Based Study of Mass Vaccination End the

Hesham Abboud1, Mauricio F Farez1

  • 1From the Multiple Sclerosis and Neuroimmunology Program (H.A.), University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH; and Center for Research on Neuroimmunological Diseases (CIEN) (M.F.F.), Fleni, Buenos Aires, Argentina.

Neurology
|August 14, 2024
PubMed
Abstract

No abstract available in PubMed .